{
    "nct_id": "NCT06052826",
    "official_title": "Geriatric (G) Assessment Guided Optimization (O) to Accelerate Functional Recovery After Chimeric Antigen Receptor T-Cell (CAR-T) Therapy for Patients 60 Years and Older With B-Cell Non-Hodgkin Lymphoma or Multiple Myeloma (GOCART)",
    "inclusion_criteria": "* Ability to provide informed consent\n* Patient's physician must agree for patient participation. A physician may elect to provide blanket agreement for participation of any eligible CAR-T patient under their care\n* Ability to read English, or Spanish. Other languages will be acceptable with site principal investigator (PI) agreement if surveys are available and language does not preclude completing study procedures\n* Age: >= 60 years at the time of enrollment\n* Scheduled to receive an Food and Drug Administration (FDA)-approved CAR-T for treatment of multiple myeloma or B-cell non- Hodgkin lymphoma\n* Willing and able to complete study requirements\n* Patients expect to be able to participate at least once before lymphodepletion with trimodality optimization visits\nHealthy volunteers allowed\nMust have minimum age of 60 Years",
    "exclusion_criteria": "* Prior CAR-T therapy\n* Any condition that would, in the Investigator's judgment, contraindicate the patient's participation in the clinical study due to safety concerns with clinical study procedures\n* Prospective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including compliance issues related to feasibility/logistics)",
    "miscellaneous_criteria": ""
}